Clinical trials
Hyperphagia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corporacion Parc Tauli | 2 |
| Fresenius Kabi | 2 |
| Shire | 2 |
| Antonio Arroyo Sebastian | 1 |
| B. Braun Medical SA | 1 |
| Fundacion Miguel Servet | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Fundación Pública Andaluza Progreso y Salud | 1 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 1 |
| Hospital Sant Joan de Deu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphagia | 18 |
| Critical Illness | 3 |
| Mental Disorders | 2 |
| Prader-Willi Syndrome | 2 |
| Premature Birth | 2 |
| Short Bowel Syndrome | 2 |
| Catheter-Related Infections | 1 |
| Colonic Neoplasms | 1 |
| Diabetes Mellitus | 1 |
| Insulin Resistance | 1 |
Trials
Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.